AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks with ADHD Medications

by bil | September 24th, 2007

The Agency for Healthcare Research and Quality (AHRQ) and the Food and Drug Administration (FDA) will team up to perform the most comprehensive study ever conducted on prescription drugs used to treat attention deficit hyperactivity disorder (ADHD). The study will address the potential for increased risk of heart attack, stroke, and other cardiovascular causes when using these drugs.

Vanderbilt University and Kaiser Permanente of California will help perform data analysis to determine whether or not these possibly dangerous medications may result in California drug injuries and deaths.

Click here to read more